Amination of Bis(trimethylsilyl)-1,2-bisketene
J . Org. Chem., Vol. 64, No. 13, 1999 4695
region δ 2.3-3.3 were suggestive of the presence of succinimide
4a and desilylation products. The product mixture was stirred
with n-Bu4NF (1.5 mL, 1.0 M in THF) in 3 mL of THF for 10
min and then diluted with 10 mL of H2O and extracted with
5 mL of ether. The organic extract was dried and evaporated
to give 4b5 as the major product by 1H NMR, and this was
purified by chromatography (2% MeOH in CH2Cl2) and identi-
d,l-5c 1H NMR (CDCl3) δ 0.11 (s, 18, Me3Si), 2.11 (s, 2,
CHSiMe3), 3.75-3.95 (m, 4, CH2CF3), 7.75 (bs, 2, NH); 13C
NMR (CDCl3) δ -1.75, 38.5, 40.7 (q, 2J CF ) 34.4 Hz), 124.2 (q,
1J CF ) 279 Hz), 175.0; 5c IR (CDCl3) 3452, 1670, 1508 cm-1
;
EIMS m/z 424 (46, M+), 73 (100, Me3Si+); HRMS m/z calcd for
C
14H26F6N2O2Si2 424.1437, found 424.1453.
Reaction of 1 (7.7 mg, 0.034 mmol) in 0.7 mL of CD2Cl2 with
1
fied by H NMR (CDCl3) peaks at δ 2.71 (s, 4, CH2CH2), 4.66
(s, 2, CH2), and 7.3-7.4 (m, 5, Ph).
CF3CH2NH2 (2.7 µL, 0.034 mmol) in an NMR tube gave after
3 h a product tentatively assigned by the 1H NMR spectrum
to contain 35% 3c: 1H NMR (CDCl3) 0.17 (s, 9, Me3Si), 2.10
(s, 1, CHSiMe3), 3.8-4.1 (m, 2, CH2CF3), 6.12 (s, 1, NH).
N-Ben zyl-N′-n -b u t yl 2,3-b is(t r im et h ylsilyl)b u t a n ed i-
a m id e (6). To a solution of 3a (0.71 mmol, generated in situ
from 0.71 mmol of 1 and 0.71 mmol of PhCH2NH2) in 8 mL of
CH2Cl2 at room temperature was added n-BuNH2 (70 µL, 0.71
mmol) in one portion. After 3 min of stirring, the solvent was
evaporated, giving 6 as a 2/1 mixture of erythro/threo dia-
stereomers in 95% crude yield and 94% purity by 1H NMR.
Chromatography (2% MeOH in CH2Cl2) gave the purified
isomers. erythro-6 (78 mg, 0.19 mmol, 27%), mp 141-144 °C:
1H NMR (CDCl3) δ 0.051 (s, 9, Me3Si), 0.055 (s, 9, Me3Si), 0.90
(t, 3, CH3), 1.3 (m, 2, CH2Me), 1.4 (m, 2, CH2Et), 2.32 (d, 1, J
) 11.2 Hz, CHCO), 2.36 (d, 1, J ) 11.2 Hz, CHCO), 3.16 (m,
2, NCH2Pr-n), 4.33 (dd, 2, CH2Ph), 5.55 (t, 1, NH), 5.90 (t, 1,
NH), 7.31 (m, 5, Ph); 13C NMR (CDCl3) δ -1.34, -1.30, 13.8,
20.2, 31.7, 37.2, 37.3, 39.3, 44.0, 127.4 128.3, 128.6, 138.1,
173.6, 173.7; IR (CDCl)3 3445, 3330, 1664, 1628 cm-1; EIMS
m/z 406, (M+, 22), 391 (M+ - CH3, 22), 315 (M+ - C7H7, 40),
200 (29), 147 (24), 91 (C7H7+, 100), 73 (Me3Si+, 77); HRMS m/z
calcd for C21H38N2O2Si2 406.2472, found 406.2484. threo-6 (26
mg, 0.064 mmol, 9%) mp 126-128 °C: 1H NMR (CDCl3) δ
0.079 (s, 9, Me3Si), 0.83 (s, 9, Me3Si), 0.92 (t, 3, CH3), 1.37 (m,
2, CH2Me), 1.50 (m, 2, CH2Et), 1.98 (d, 1, J ) 5.2 Hz, CHCO),
2.02 (d, 1, J ) 5.2 Hz, CHO), 3.2 (m, 2, CH2Pr-n), 4.4 (m, 2,
CH2Ph), 7.3 (m, 5, Ph); 7.36 (s, 1, NH); 7.87 (s, 1, NH). 13C
NMR (CDCl3) δ -1.37, -1.30, 13.8, 20.3, 31.7, 38.4, 38.5, 39.6,
43.9, 127.2, 128.1, 128.5, 138.5, 174.3, 174.4; IR (CDCl3) δ 3445,
N-n -Bu tyl-2,3-bis(tr im eth ylsilyl)-4-oxobu t-3-en a m id e
(3b). To bisketene 1 (265 mg, 1.17 mmol) in 4 mL of CH2Cl2
stirred at 25 °C was added n-BuNH2 (114 µL, 84.4 mg, 1.15
mmol) in 3 mL of CH2Cl2. After the exothermic reaction, the
solution was stirred 5 min and then cooled to -70 °C for
storage. A 1 mL aliquot was evaporated to give 3b as a white
solid, mp 73-77 °C: 1H NMR (CDCl3) δ 0.148 (s, 9, Me3Si),
0.155 (s, 9, Me3Si), 0.91 (t, 3, J ) 7.3 Hz, CH3), 1.3-1.6 (m, 4,
CH2CH2), 1.85 (s, 1, CH), 3.2-3.3 (m, 2, NCH2); 13C NMR
(CDCl3) δ -2.09, -1.06, 10.7, 13.6, 20.1, 31.9, 32.1, 39.5, 173.1,
CH CN
179.8; IR (CH2Cl2) 3443, 2077, 1653, 1509 cm-1; UV λmax
3
332 nm, ꢀ ) 40; EIMS m/z 299 (M+, 21), 198 (M+ - CONH2-
Bu-n, 100), 73 (Me3Si+, 67); HRMS m/z calcd for C14H29NO2-
Si2 299.1737, found 299.1738.
N,N′-Diben zyl-2,3-bis(tr im eth ylsilyl)su ccin a m id e (m e-
so- a n d d ,l-5a ). Bisketene 1 (206 mg, 0.912 mmol) in 3 mL of
CH2Cl2 was added in one portion to a stirred solution of
benzylamine (198 µL, 1.81 mmol) in 3 mL of CH2Cl2 at room
temperature, with transient generation of a pink color. After
2 min of stirring, the solvent was evaporated, giving crude 5a
(0.37 mg, 0.84 mmol, 92%) which by 1H NMR analysis
consisted of meso- and d,l-5a in a 1.0/1.0 ratio, with about 4%
of an impurity tentatively identified as a desilylated product.
Radial chromatography on silica gel (2% Et3N in CH2Cl2)
separated the diastereomeric products: meso-5a (89 mg, 0.20
1
mmol, 22%) mp 149-152 °C; H NMR (CDCl3) δ 0.06 (s, 18,
Me3Si), 2.39 (s, 2, J C,H ) 125 Hz, J H,H ) 11.1 Hz, CHSiMe3),
4.31 (d, 4, CH2Ph), 5.89 (t, 2, NH), 7.3 (m, 10, Ph); 13C NMR
(CDCl3) δ -1.2, 37.2, 44.0, 127.4, 128.3, 128.5, 138.0, 173.6;
IR (CDCl3) 3446, 1649, 1499 cm-1; EIMS m/z 440 (M+, 14),
349 (M+ - Bn, 26), 91 (PhCH2+, 100), 73 (Me3Si+, 54); HRMS
m/z calcd for C24H36N2O2Si2 440.2315, found 440.2309. d,l-5a
(32 mg, 0.073 mmol, 8%) mp 146-148 °C;1H NMR (CDCl3) 0.07
(s, 18, Me3Si), 2.05 (s, 2, J C,H ) 119 Hz, J H,H ) 5.1 Hz), 4.35
(m, 4, CH2Ph), 7.3 (m, 10, Ph), 7.82 (bs, 2, NH); 13C NMR
(CDCl3) δ -1.3, 38.4, 44.0, 127.2, 128.1, 128.5, 138.4, 174.3;
IR (CDCl3) 3447, 1649, 1503 cm-1; EIMS m/z 440 (M+, 10),
349 (M+ - PhCH2, 21), 91 (C7H7+, 100), 73 (Me3Si+, 40); HRMS
m/z calcd for C24H36N2O2Si2 440.2315, found 440.2319.
3257, 1656, 1621 cm-1; EIMS m/z 406 (M+, 31), 315 (M+
-
C7H7, 70), 91 (C7H7+, 100); 73 (Me3Si+, 87); HRMS m/z calcd
for C21H38N2O2Si2 406.2472, found 406.2470.
N-P h en ylim in o-3,4-bis(tr im eth ylsilyl)su ccin im id e (7).
To a stirred solution of 1 (173 mg, 0.763 mmol) in 3 mL of
CH2Cl2 at room temperature was added phenylhydrazine (75
µL, 0.76 mmol) in CH2Cl2. After 10 min of stirring, the solvent
was evaporated and 1H NMR analysis showed that one
stereoisomer of 7 was formed to the extent of 90%. Upon
chromatography (10% EtOAc in hexanes, silica gel) the major
stereoisomer was isolated in 95% purity, as a yellow solid, mp
144-158 °C (decomp): 1H NMR (CDCl3) δ 0.16 (s, 18, Me3Si),
2.34 (s, 2, CHCO), 6.08 (s, 1, NH), 6.8-7.2 (m, 5, Ph); 13C NMR
(CDCl3) δ -3.1, 33.4, 115.6, 122.7, 129.1, 132.1, 176.9; IR (CCl4)
3344 (w), 1703 cm-1; EIMS m/z 334 (M+, 42), 242 (M+ - NHPh,
52), 150 (32), 91 (19), 73 (Me3Si+, 100); HRMS m/z calcd for
N,N′-Di-n -bu tyl-2,3-bis(tr im eth ylsilyl)su ccin am ide (me-
so- a n d d ,l-5b). Bisketene 1 (182 mg, 0.804 mmol) in 3 mL of
CH2Cl2 was added in one portion to n-BuNH2 (158 µL, 1.60
mmol) as in the preparation of 5a . The solid product was
obtained in 85% crude yield and 89% purity by 1H NMR, with
a meso/dl ratio of 3/2: meso-5b 1H NMR (CDCl3) δ 0.06 (s, 18,
Me3Si), 0.92 (t, 6, CH3), 1.4 (m, 8, MeCH2CH2), 2.28 (s, 2,
CHSiMe3), 3.32 (m, 4, CH2N), 5.4 (t, 2, NH); d,l-5b 1H NMR
(CDCl3) δ 0.10 (s, 18, Me3Si), 0.92 (t, 6, CH3), 1.4 (m, 8,
MeCH2CH2), 1.96 (s, 2, CHSiMe3), 3.32 (m, 4, CH2N), 7.4 (t,
C
16H26N2O2Si2 334.1533, found 334.1525.
er yth r o-N-n -Bu tyl 2,3-bis(tr im eth ylsilyl)-4-m eth oxy-4-
oxobu ta n a m id e (8a ). Methanol (2 mL) was added to solid
3b (25 mg, 0.084 mmol) at room temperature, and after 5 min
the resulting solution was evaporated to give a pale yellow
2, NH); IR (CDCl3) 3447, 1651, 1508 cm-1
.
solid which by H NMR consisted of erythro-8a with less than
1
N,N′-Bis(tr iflu or oeth yl)-2,3-bis(tr im eth ylsilyl)su ccin -
a m id e (m eso- a n d d ,l-5c). To a stirred solution of bisketene
1 (131 mg, 0.58 mmol) in 3 mL of CH2Cl2 was added CF3CH2-
NH2 (0.280 mL, 3.52 mmol) at room temperature, and the
solution was stirred for 3 h. The 1H NMR showed 10% residual
1; therefore, 0.050 mL of additional CF3CH2NH2 was added,
the solution was stirred for 1.5 h, and the solvent was
evaporated to give a pale yellow solid that was not completely
10% of any impurities or isomeric byproducts. This was
recrystallized from pentane to give erythro-8a , mp 102-105
°C: 1H NMR (CDCl3) δ 0.045 (s, 9, Me3Si), 0.064 (s, 9, Me3Si),
0.91 (t, 3, J ) 7.3 Hz, CH3), 1.33 (sextet, 2, J ) 7.4 Hz, CH2),
1.47 (quintet, 2, J ) 7.1 Hz, CH2), 2.45 (d, 2, J ) 11.5 Hz,
CH), 2.66 (d, 2, J ) 11.5 Hz, CH), 3.18 (q, 2, J ) 7.1 Hz, CH2N),
3.59 (s, 3, OCH3), 5.28 (bs, 1, NH); 13C NMR (CDCl3) δ -1.80,
-1.46, 13.7, 20.2, 31.7, 35.4, 37.3, 39.3, 50.9, 173.1, 175.6; IR
(CDCl3) 3450, 1707, 1656, 1505 cm-1; EIMS m/z 331 (M+, 13),
258 (M+ - SiMe3, 41), 73 (Me3Si+, 75); HRMS m/z calcd for
1
soluble in CDCl3 and by H NMR contained meso- and d,l-5c
in a 1.2/1.0 ratio. The solid product was fractionated by partial
dissolution in 4/1 pentane/CH2Cl2 to give a soluble fraction
from which a solid rich in meso-5c crystallized on cooling and
an insoluble fraction rich in d,l-5c was obtained: meso-5c 1H
NMR (CDCl3) 0.079 (s, 18, Me3Si), 2.45 (s, 2, CHSiMe3), 3.9-
4.05 (m, 4, CH2CF3), 5.78 (bs, 2, NH); 13C NMR (CDCl3) δ
-1.59, 37.5, 40.6 (2J CF ) 34.4 Hz), 124.1 (1J CF ) 279 Hz), 174.1;
C
15H33NO3Si2 331.1999, found 331.2005.
N-Ben zyl-2,3-b is(t r im et h ylsilyl)-4-m et h oxy-4-oxob u -
ta n a m id e (8b). Bisketene 1 (259 mg, 1.14 mmol) was slowly
added via syringe to 13 mL of CH3OH at 0 °C, and after 7 min
of stirring, the CH3OH was evaporated at 25 °C to give ketenyl
ester 10a , which was dissolved in 3 mL of CH2Cl2. To the